We could predict the role of VVO in modulating the serotonergic synaptic pathway in the treatment of insomnia, and this modulation was associated with MAOB, MAOA, PTGS2, HTR2A, and SLC6A4. The gene discussed is PTGS2; the disease is insomnia measurement.